Clinical Trials Nct Page
Clinical Trial Results:
A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with LAF237 50 mg bid to rosiglitazone 8 mg qd in drug naïve patients with type 2 diabetes
| Summary | |
EudraCT number | 2004-005045-35 |
Trial protocol | SE |
Global completion date | 28 Sep 2005 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v2(current) |
This version publication date | 20 May 2017 |
First version publication date | 03 Mar 2017 |
Other versions | v1 |
Version creation reason |
|
Summary report(s) | CLAF237A2327 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.